Pharmacologic rationale, efficacy and safety of the fixed-dose co-formulation of indacaterol and glycopyrronium

Chronic obstructive pulmonary disease (COPD) is a widespread respiratory disorder, usually characterized by progressive and poorly reversible airflow limitation. Inhaled long-acting bronchodilators, namely LABA (long-acting β(2)-adrenergic agonists) and LAMA (long-acting muscarinic receptor antagoni...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelaia, Girolamo, Maselli, Rosario, Gallelli, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333835/
https://www.ncbi.nlm.nih.gov/pubmed/25699181
http://dx.doi.org/10.1186/2049-6958-9-64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333835/
https://www.ncbi.nlm.nih.gov/pubmed/25699181
http://dx.doi.org/10.1186/2049-6958-9-64

Ejemplares similares